Market News / Story
Haemonetics Corporation Stock 12‑Month Price Target Raised to $115.5, Implies 14% Upside
·
According to estimates from 10 analysts, Haemonetics Corporation stock's average price target has risen from $113.5 to $115.5, with forecasts ranging from $86 to $140 per share Based on the Oct. 7 closing price, the updated target implies approximately 14% potential upside Consensus rating remains at “Buy” across 12 covering analysts, with 9 Buys, 3 Holds and 0 Sells Explore more price target data and ratings for Haemonetics Corporation on the Forecasts tab , and track…